Non-opioids Flashcards
What is an NSAID?
NSAIDs are drugs that act to relieve inflammation but are not structurally related to the corticosteroids.
3 effects of NSAID
- Analgesic
- Antipyretic
- Anti-inflammatory (at higher doses)
How do NSAID’s work?
Dampens the body’s inflammatory response by inhibiting COX-2 enzyme (COX-1 is inhibited as well)
Possible side effects of NSAID’s
Ulcers because of COX-1 inhibition, gastric haemorrhage, Reye’s syndrome in children (aspirin), ARF
How does paracetamol/acetaminophen work?
Activates cannabinoid receptors
What is COX?
An enzyme that is responsible for formation of prostanoids, including thromboxane and prostaglandins such as prostacyclin.
Where is COX-1 found?
Exists in the tissue as constitutive isoform
Where is COX-2 found?
At site of inflammation, cytokines stimulate the induction of the 2nd isoform
How is COX-2 inhibited
Anti-inflammatory actions of NSAIDs.
Prostaglandin synthesis pathway
Membrane phospholipid -> arachnoidid acid
Then Physiological regulation by COX-1 and Inflammatory response by newly expressed COX-2.
NSAID Analgesic effects
(CNS and peripheral effect) may involve non-
PG related effects
Not very strong
NSAID Antipyretic effects
(CNS effect) Reduce/increase body temperature
NSAID Anti-inflammatory effects
(except acetaminophen) due mainly to PG inhibition (particularly COX-2 inhibitors)
Uricosuric
Drugs that promote the excretion of uric acid
COX-2 central cytokine release
- COX-2 upregulation in dorsal horn neurones and supporting cells
- Prostogalndin production (also via COX-1)
- Action on PGE2 receptors on dorsal horn neurones
- Enhanced depolarisation of secondary neurones.
COX-2 peripheral inflammation
- COX-2 upregulation in inflammatory cells
- Prosogladin production
- Action of peripheral terminal PGE2 receptors
- Peripehral sensitization
NSAIDs effect on peripheral inflammation?
Inhibit COX 2 so prostaglandins cannot be produced. Preventing development of peripheral sensitization
NSAIDs effect on central cytokine release?
Inhibit COX 2 (and COX-1) so prostaglandins cannot be produced. Preventing enhanced depolarisation of secondary sensory neurones.
Inhibition of COX-1 is responsible for their GIT toxicity.
Gastritis and peptic ulceration with bleeding and perforation (inhibition of PG + other effects).
Effect on Respiration: triphasic (Aspirin)
- Low doses: uncoupling phosphorylation → ↑ CO2 → stimulates
respiration. - Direct stimulation of respiratory center → Hyperventilation → resp.
alkalosis → renal compensation. - Depression of respiratory center and cardiovascular center → ↓ BP,
respiratory acidosis, no compensation + metabolic acidosis also.
GI system (Aspirin)
- Dose dependent hepatitis.
2. Reye’s syndrome (liver and brain damage in children 9-12).
Metabolic (Aspirin)
- Uncoupling of Oxidative Phosphorylation.
2. Hyperglycemia and depletion of muscle and hepatic glycogen.
Endocrine: (Aspirin)
corticosteroids, thyroid.
Cardiovascular (Aspirin)
- Platelets: Inhibition of platelet COX-1-derived TxA2with the net effect of
increasing bleeding time (inhibition of platelet aggregation). - Endothelial COX-2 derived PGI2can inhibit platelet aggregation (inhibition
augments aggregation by TxA2). - Aspirin (acetylsalicylic acid) covalently modifies and, irreversibly inhibits
platelet COX. The enzyme is inhibited for the lifetime of the platelet (~8 -11
days). Effect achieved at very low dose. - Basis of therapeutic efficacy in stroke and MI (reduces mortality and
prevents recurrent events).